{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:54:11Z","timestamp":1787849651662,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T00:00:00Z","timestamp":1618272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017183","name":"Janssen Scientific Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017183","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofvascularsurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Vascular Surgery"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.avsg.2021.02.025","type":"journal-article","created":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T11:11:58Z","timestamp":1617361918000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-7201","authenticated-orcid":false,"given":"Urvi","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Kharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie N.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejan","family":"Milentijevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2601-6214","authenticated-orcid":false,"given":"Fran\u00e7ois","family":"Lalibert\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Zuckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4294-6024","authenticated-orcid":false,"given":"John","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Hiatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Bonaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.avsg.2021.02.025_bib0001","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","article-title":"Peripheral artery disease: past, present, and future","volume":"132","author":"Campia","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.avsg.2021.02.025_bib0002","unstructured":"Centers for Disease Control and Prevention (CDC). Peripheral arterial disease (PAD) fact sheet. 2019; Available at: https:\/\/www.cdc.gov\/dhdsp\/data_statistics\/fact_sheets\/fs_pad.htm. Accessed May 26, 2020."},{"key":"10.1016\/j.avsg.2021.02.025_bib0003","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nurpra.2018.09.008","article-title":"Update: diagnosis and management of peripheral arterial disease","volume":"15","author":"Kohlman-Trigoboff","year":"2019","journal-title":"J Nurse Pract"},{"key":"10.1016\/j.avsg.2021.02.025_bib0004","first-page":"e686","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines","volume":"135","author":"Gerhard-Herman","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2021.02.025_bib0005","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1161\/CIRCULATIONAHA.117.024469","article-title":"A structured review of antithrombotic therapy in peripheral artery disease with a focus on revascularization: a TASC (InterSociety consensus for the management of peripheral artery disease) initiative","volume":"135","author":"Hess","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2021.02.025_bib0006","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","article-title":"Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease","volume":"120","author":"Diehm","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2021.02.025_bib0007","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/1358863X13493825","article-title":"Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the heart and soul study","volume":"18","author":"Grenon","year":"2013","journal-title":"Vasc Med"},{"key":"10.1016\/j.avsg.2021.02.025_bib0008","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.amjcard.2019.03.022","article-title":"Incidence and cost of major adverse cardiovascular events and major adverse limb events in patients with chronic coronary artery disease or peripheral artery disease","volume":"123","author":"Berger","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.avsg.2021.02.025_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2016.2024","article-title":"Effectiveness of a medical vs. revascularization intervention for intermittent leg claudication based on patient-reported outcomes","volume":"151","author":"Devine","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.avsg.2021.02.025_bib0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/CIRCULATIONAHA.106.643346","article-title":"Quantifying improvement in symptoms, functioning, and quality of life after peripheral endovascular revascularization","volume":"115","author":"Safley","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2021.02.025_bib0011","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.115.019355","volume":"133","author":"Bonaca","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2021.02.025_bib0012","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.116.025880","article-title":"Ticagrelor compared with clopidogrel in patients with prior lower extremity revascularization for peripheral artery disease","volume":"135","author":"Jones","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2021.02.025_bib0013","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2021.02.025_bib0014","doi-asserted-by":"crossref","first-page":"A14170","DOI":"10.1161\/circ.142.suppl_3.14170","article-title":"Reduction in venous thromboembolism with rivaroxaban versus placebo in peripheral artery disease after lower extremity revascularization: insights from VOYAGER PAD","volume":"142","author":"Hess","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.avsg.2021.02.025_bib0015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jacc.2019.11.050","article-title":"Long-term outcomes and associations with major adverse limb events after peripheral artery revascularization","volume":"75","author":"Hess","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2021.02.025_bib0016","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jacc.2018.06.041","article-title":"Major adverse limb events and 1-year outcomes after peripheral artery revascularization","volume":"72","author":"Hess","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.avsg.2021.02.025_bib0017","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jvs.2017.01.061","article-title":"Regional variation in outcomes for lower extremity vascular disease in the vascular quality initiative","volume":"66","author":"Soden","year":"2017","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2021.02.025_bib0018","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","article-title":"Rivaroxaban in peripheral artery disease after revascularization","volume":"382","author":"Bonaca","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.avsg.2021.02.025_bib1019","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries","volume":"173","author":"Quan","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.avsg.2021.02.025_bib0019","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simul Comput"},{"key":"10.1016\/j.avsg.2021.02.025_bib0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"issue":"3 Suppl","key":"10.1016\/j.avsg.2021.02.025_bib0021","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/j.jvs.2014.12.009","article-title":"Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication","volume":"61","author":"Conte","year":"2015","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.avsg.2021.02.025_bib0022","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ahj.2019.11.007","article-title":"Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial","volume":"220","author":"Ward","year":"2020","journal-title":"Am Heart J"}],"container-title":["Annals of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509621002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890509621002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:01:40Z","timestamp":1760187700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890509621002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":23,"alternative-id":["S0890509621002259"],"URL":"https:\/\/doi.org\/10.1016\/j.avsg.2021.02.025","relation":{},"ISSN":["0890-5096"],"issn-type":[{"value":"0890-5096","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Major Atherothrombotic Vascular Events among Patients with Peripheral Artery Disease after Revascularization","name":"articletitle","label":"Article Title"},{"value":"Annals of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.avsg.2021.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Janssen Scientific Affairs, LLC. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}